These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1717291)

  • 1. Species differences in affinities of non-peptide antagonists for substance P receptors.
    Gitter BD; Waters DC; Bruns RF; Mason NR; Nixon JA; Howbert JJ
    Eur J Pharmacol; 1991 May; 197(2-3):237-8. PubMed ID: 1717291
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonists that demonstrate species differences in neurokinin-1 receptors.
    Appell KC; Fragale BJ; Loscig J; Singh S; Tomczuk BE
    Mol Pharmacol; 1992 Apr; 41(4):772-8. PubMed ID: 1373802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist.
    McLean S; Ganong AH; Seeger TF; Bryce DK; Pratt KG; Reynolds LS; Siok CJ; Lowe JA; Heym J
    Science; 1991 Jan; 251(4992):437-9. PubMed ID: 1703324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels.
    Schmidt AW; McLean S; Heym J
    Eur J Pharmacol; 1992 Sep; 219(3):491-2. PubMed ID: 1385177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences between [3H] substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists.
    Fardin V; Garret C
    Eur J Pharmacol; 1991 Aug; 201(2-3):231-4. PubMed ID: 1724651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in affinities for the NK1 receptor: differences between the non-peptide substance P antagonists RP 67580 and CP-96,345 and the agonist septide.
    Fardin V; Foucault F; Bock MD; Jolly A; Flamand O; Clerc F; Garret C
    Regul Pept; 1993 Jul; 46(1-2):300-3. PubMed ID: 7692521
    [No Abstract]   [Full Text] [Related]  

  • 7. A potent nonpeptide antagonist of the substance P (NK1) receptor.
    Snider RM; Constantine JW; Lowe JA; Longo KP; Lebel WS; Woody HA; Drozda SE; Desai MC; Vinick FJ; Spencer RW
    Science; 1991 Jan; 251(4992):435-7. PubMed ID: 1703323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective and potent antagonist of substance P receptors on pancreatic acinar cells.
    Sjödin L; Gylfe E
    Biochem Int; 1992 Jun; 27(1):145-53. PubMed ID: 1378274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P.
    Rouissi N; Gitter BD; Waters DC; Howbert JJ; Nixon JA; Regoli D
    Biochem Biophys Res Commun; 1991 Apr; 176(2):894-901. PubMed ID: 1709018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580.
    Fong TM; Yu H; Strader CD
    J Biol Chem; 1992 Dec; 267(36):25668-71. PubMed ID: 1281470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345.
    Beresford IJ; Birch PJ; Hagan RM; Ireland SJ
    Br J Pharmacol; 1991 Oct; 104(2):292-3. PubMed ID: 1665729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and substance P receptor binding activity of androstano[3,2-b]pyrimido[1,2-a]benzimidazoles.
    Venepalli BR; Aimone LD; Appell KC; Bell MR; Dority JA; Goswami R; Hall PL; Kumar V; Lawrence KB; Logan ME
    J Med Chem; 1992 Jan; 35(2):374-8. PubMed ID: 1370695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
    Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
    Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved HisVI-17 of the NK-1 receptor is involved in binding of non-peptide antagonists but not substance P.
    Zoffmann S; Gether U; Schwartz TW
    FEBS Lett; 1993 Dec; 336(3):506-10. PubMed ID: 7506676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-peptide antagonists, CP-96,345 and RP 67580, distinguish species variants in tachykinin NK1 receptors.
    Barr AJ; Watson SP
    Br J Pharmacol; 1993 Jan; 108(1):223-7. PubMed ID: 7679031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96,345, a new non-peptide NK1 receptor antagonist.
    Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1992 Feb; 105(2):261-2. PubMed ID: 1373095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.
    Gether U; Yokota Y; Emonds-Alt X; Brelière JC; Lowe JA; Snider RM; Nakanishi S; Schwartz TW
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6194-8. PubMed ID: 7687062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.
    Snider RM; Longo KP; Drozda SE; Lowe JA; Leeman SE
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10042-4. PubMed ID: 1719543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor.
    Cascieri MA; Ber E; Fong TM; Sadowski S; Bansal A; Swain C; Seward E; Frances B; Burns D; Strader CD
    Mol Pharmacol; 1992 Sep; 42(3):458-63. PubMed ID: 1383685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B.
    Ploux O; Lavielle S; Chassaing G; Julien S; Marquet A; d'Orléans-Juste P; Dion S; Regoli D; Beaujouan JC; Bergström L
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8095-9. PubMed ID: 2446317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.